longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Nexgel

NXGL

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -0.27, above the reasonable range, cheaper than 0% of the time in the past 1 years, and the industry ranks 22/45, the industry Median -0.27.

-0.272xP/E
$0.17Stock price
$-0.63Earnings per share
-0.272xP/E
Stock price$0.17Earnings per share$-0.63

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-1.83x
Typical range
-4.72x–-1.31x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
017345168

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
BLCOUSBausch + Lomb
-35.51x94.03%$6.07B
MMEDUSMiniMed
-17.45x146.72%$5.48B
NEOGUSNeogen
-353.31x316.68%$2.79B
ESTAUSEstablishment Labs
-49.17x30.16%$1.91B
XRAYUSDentsply Sirona
-3.23x113.34%$1.77B
KIDSUSOrthopediatrics
-14.64x27.74%$581.46M
CERSUSCerus
-70.71x56.25%$479.63M
SMTIUSSanara Medtech
-10.08x104.59%$322.87M
OSURUSOraSure Tech
-5.50x29.79%$270.36M
RXSTUSRxSight
-4.34x0.58%$203.81M
SKYAUSSkyAI
-0.21x--$84.33M
ZTEKFUSZENTEK LTD
-7.44x--$55.80M
TELAUSTela Bio
-1.25x17.47%$51.63M
XTNTUSXtant Med
-4.47x477.77%$49.82M
RMTIUSRockwell Medical
-6.57x32.67%$34.42M
NSPRUSInspireMD
-0.59x--$31.05M
RVPUSRetractable Tech
-5.74x--$20.69M
CUPRUSCuprina
-4.43x--$15.97M
LUCYUSInnovative Eyewear
-1.02x--$7.84M
AIDXUS20/20 Biolabs
-0.78x44.74%$5.57M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.